The effect of eribulin treatment for patients with HER2-low breast cancer

被引：0
|
作者：
Goto, Wataru
Henmi, Saeko
Nishikawa, Mariko
Kouchi, Asuka
Kouhashi, Rika
Yabumoto, Akimichi
Takada, Koji
Asano, Yuka
Tauchi, Yukie
Ogisawa, Kana
Morisaki, Tamami
Kashiwagi, Shinichiro
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-05-11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-05-11
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Biology and Treatment of HER2-Low Breast Cancer
    Nicolo, Eleonora
    Tarantino, Paolo
    Curigliano, Giuseppe
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (01) : 117 - 132
  • [2] HER2-low breast cancer: a new concept in breast cancer treatment strategy
    Deluche, Elise
    Vincent-Salomon, Anne
    BULLETIN DU CANCER, 2021, 108 (11) : S1 - S7
  • [3] Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine
    Kitadai, Rui
    Shimoi, Tatsunori
    Yazaki, Shu
    Okuma, Hitomi Sumiyoshi
    Hoshino, Mai
    Ito, Munehiro
    Saito, Ayumi
    Kita, Shosuke
    Kojima, Yuki
    Nishikawa, Tadaaki
    Sudo, Kazuki
    Noguchi, Emi
    Fujiwara, Yasuhiro
    Yoshida, Masayuki
    Yonemori, Kan
    BREAST CANCER, 2024, 31 (06) : 1037 - 1045
  • [4] Challenges in HER2-low breast cancer identification, detection, and treatment
    Wu, Qian
    Xu, Ling
    TRANSLATIONAL BREAST CANCER RESEARCH, 2024, 5
  • [5] HER2-low breast cancer: Novel detections and treatment advances
    Wu, Yun
    Zhong, Ruiqi
    Ma, Fei
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 181
  • [6] New treatment options for metastatic HER2-low breast cancer
    Denkert, Carsten
    Lebeau, Annette
    Schildhaus, Hans Ulrich
    Jackisch, Christian
    Rueschoff, Josef
    PATHOLOGIE, 2023, 44 (02): : S53 - S60
  • [7] The Exciting New Field of HER2-Low Breast Cancer Treatment
    Eiger, Daniel
    Agostinetto, Elisa
    Saude-Conde, Rita
    de Azambuja, Evandro
    CANCERS, 2021, 13 (05) : 1 - 18
  • [8] Characteristics and clinical outcomes of patients with HER2-low breast cancer
    Koh, S.
    Koi, Y.
    Tajiri, W.
    Kawasaki, J.
    Akiyoshi, S.
    Nakamura, Y.
    Koga, C.
    Tokunaga, E.
    BREAST, 2023, 68 : S32 - S32
  • [9] Clinicopathological features and prognosis of patients with HER2-low breast cancer
    Xin Yang
    Yao Li
    Xu lu
    Xiaotian Ren
    Bin Hua
    BMC Cancer, 23 (1)
  • [10] Clinicopathological features and prognosis of patients with HER2-low breast cancer
    Yang, Xin
    Li, Yao
    Lu, Xu
    Ren, Xiaotian
    Hua, Bin
    BMC CANCER, 2023, 23 (01)
12345